Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Free Cash Flow (2016)

Lixte Biotechnology Holdings' Free Cash Flow history spans 7 years, with the latest figure at -$469842.0 for Q4 2016.

  • For Q4 2016, Free Cash Flow changed N/A year-over-year to -$469842.0; the TTM value through Dec 2016 reached -$1.7 million, down 6.92%, while the annual FY2025 figure was -$3.1 million, 2.97% up from the prior year.
  • Free Cash Flow reached -$469842.0 in Q4 2016 per LIXT's latest filing, up from -$480132.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$248963.0 in Q1 2012 to a low of -$7.1 million in Q4 2013.
  • Average Free Cash Flow over 5 years is -$2.6 million, with a median of -$515112.0 recorded in 2015.
  • Peak YoY movement for Free Cash Flow: crashed 226.67% in 2012, then soared 39.5% in 2016.
  • A 5-year view of Free Cash Flow shows it stood at -$5.9 million in 2012, then dropped by 20.04% to -$7.1 million in 2013, then skyrocketed by 94.89% to -$361488.0 in 2014, then tumbled by 40.79% to -$508935.0 in 2015, then increased by 7.68% to -$469842.0 in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Free Cash Flow are -$469842.0 (Q4 2016), -$480132.0 (Q3 2016), and -$401588.0 (Q2 2016).